D.C. Mun. Regs. tit. 17, r. 17-6517
For the purposes of this section only, the following terms shall have the meanings ascribed:
A licensed pharmacist may be certified by the Department of Health (the "Department") to prescribe and dispense up to a twelve (12)-month supply of self- administered hormonal contraceptive if the licensed pharmacist:
Only pharmacists certified by the Department pursuant to this section are eligible to prescribe and dispense self-administered hormonal contraceptives. Only the certified pharmacist who prescribes the self-administered hormonal contraceptive shall dispense it to the individual for whom it was prescribed.
The certified pharmacist shall make information concerning all forms of contraception, including Long-Acting Reversible Contraceptives, approved by the U.S. Food and Drug Administration available to the patient using, at a minimum, the information pamphlet developed by the Board of Pharmacy and the Department before prescribing a self-administered hormonal contraceptive to the patient.
The patient shall complete the self-screening questionnaire developed by the Boards of Pharmacy and Medicine, which shall identify patient risk factors for the use of self-administered hormonal contraceptives, based on the current United States Medical Eligibility Criteria for Contraceptive Use developed by the Centers for Disease Control and Prevention.
The certified pharmacist shall determine if a prescription for self-administered hormonal contraceptives is medically appropriate, and the duration of the prescription if it is, based on the assessment of the self-screening questionnaire using the protocol developed by the Boards of Pharmacy and Medicine.
The certified pharmacist shall obtain the patient's informed consent to the contraceptive to be prescribed before prescribing and dispensing a self- administered hormonal contraceptive to the patient. A person under eighteen (18) years of age may provide informed consent to the contraceptive pursuant to subsection 22 -B DCMR §§ 600.7.
When a self-administered hormonal contraceptive is prescribed and dispensed, the certified pharmacist shall provide the patient, in a manner that ensures patient confidentiality, the following:
Upon prescribing and dispensing a self-administered hormonal contraceptive pursuant to this section, or if it is determined that the use of a self-administered hormonal contraceptive is not recommended, the certified pharmacist shall, using the Hormonal Contraceptive Referral and Visit Summary form developed by the Board of Pharmacy, refer the patient to the patient's primary care provider or reproductive health provider. If the patient does not have a primary care provider or reproductive health provider, the certified pharmacist shall, using the Hormonal Contraceptive Referral and Visit Summary form developed by the Board of Pharmacy, refer the patient to a nearby clinic for continuing health care.
In order to obtain a subsequent prescription of a self-administered hormonal contraceptive prescription from a pharmacist, a patient must verify in the self- screening assessment that a primary care physician or reproductive health provider has examined them within the twelve (12) month period prior to the date the subsequent prescription.
The certified pharmacist shall maintain records at the pharmacy practice site where the prescription was written and administered in accordance with the requirements of 22-B DCMR §§ 1913. In addition to the information required pursuant to 22-A DCMR §§ 1913.4, the records shall include:
The records required to be maintained pursuant to this section shall be readily available for inspection upon request of the Board of Pharmacy or submitted to the Board of Pharmacy for review upon request.
The pharmacy at which the certified pharmacist practices shall display in its stores and online a list of the times during which the certified pharmacist is available.
The Board of Pharmacy shall maintain a list of all certified pharmacists, including the location of the pharmacies where the certified pharmacists practice, and shall make the list readily accessible to the public.
The Board of Pharmacy shall provide all pharmacists licensed by the District annual notice of the requirements of this section, including opportunities for training.
D.C. Mun. Regs. tit. 17, r. 17-6517